
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1008 | 1008 | 1001 | 990 | 1407 | 2131 |
Fund Return | 0.83% | 0.83% | 0.15% | -0.32% | 7.06% | 7.86% |
Place in category | 255 | 255 | 83 | 190 | 107 | 15 |
% in Category | 36 | 36 | 10 | 31 | 22 | 3 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech I CHF | 1.37B | 1.00 | 0.38 | 8.63 | ||
Adamant Medtech T CHF | 1.37B | 0.93 | 0.08 | 8.29 | ||
Baloise Fund Invest Lux BFI C QUADr | 127.05M | -3.51 | -0.77 | -0.47 | ||
Entrepreneur Europe small B CHF | 116.83M | 7.02 | 0.80 | 4.99 | ||
Entrepreneur Europe small I CHF | 116.83M | 7.21 | 1.51 | 5.75 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech I CHF | 1.37B | 1.00 | 0.38 | 8.63 | ||
Adamant Medtech T CHF | 1.37B | 0.93 | 0.08 | 8.29 | ||
BB Adamant Global Healthcare Index | 152.02M | -1.04 | -4.40 | 4.77 | ||
BB Adamant Global Medtech und Serv | 67.17M | 4.36 | -2.10 | 7.59 | ||
BB Adamant Global Medtech und Servi | 67.17M | 4.52 | -1.51 | 8.21 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Abbott Labs | US0028241000 | 10.16 | 127.40 | +0.41% | |
Boston Scientific | US1011371077 | 10.00 | 93.94 | +0.28% | |
Stryker | US8636671013 | 9.83 | 350.13 | -0.04% | |
Intuitive Surgical | US46120E6023 | 9.37 | 489.24 | -0.88% | |
EssilorLuxottica | FR0000121667 | 5.09 | 247.10 | +2.45% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review